Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the
pharmacokinetics (the exposure of the trial drug in the body) of four lots of turoctocog alfa
(a human recombinant coagulation factor VIII (FVIII)) in subjects with haemophilia A.